[go: up one dir, main page]

IL135983A0 - Adenovirus vectors and method for reducing homologous recombination phenomena - Google Patents

Adenovirus vectors and method for reducing homologous recombination phenomena

Info

Publication number
IL135983A0
IL135983A0 IL13598398A IL13598398A IL135983A0 IL 135983 A0 IL135983 A0 IL 135983A0 IL 13598398 A IL13598398 A IL 13598398A IL 13598398 A IL13598398 A IL 13598398A IL 135983 A0 IL135983 A0 IL 135983A0
Authority
IL
Israel
Prior art keywords
homologous recombination
adenovirus vectors
recombination phenomena
reducing
reducing homologous
Prior art date
Application number
IL13598398A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9513447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL135983(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL135983A0 publication Critical patent/IL135983A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Ticket-Dispensing Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL13598398A 1997-11-17 1998-11-17 Adenovirus vectors and method for reducing homologous recombination phenomena IL135983A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714383A FR2774699B1 (fr) 1997-11-17 1997-11-17 Methode de reduction des evenements de recombinaison homologue
PCT/FR1998/002453 WO1999025861A2 (fr) 1997-11-17 1998-11-17 Vecteurs adenoviraux et methode de reduction des evenements de recombinaison homologue

Publications (1)

Publication Number Publication Date
IL135983A0 true IL135983A0 (en) 2001-05-20

Family

ID=9513447

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13598398A IL135983A0 (en) 1997-11-17 1998-11-17 Adenovirus vectors and method for reducing homologous recombination phenomena
IL135983A IL135983A (en) 1997-11-17 2000-05-04 Adenoviral vectors and a method for reducing the frequency of inter- or intra-molecular homologous recombination between chromosomal nucleic acids and extra-chromosomal nucleic acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL135983A IL135983A (en) 1997-11-17 2000-05-04 Adenoviral vectors and a method for reducing the frequency of inter- or intra-molecular homologous recombination between chromosomal nucleic acids and extra-chromosomal nucleic acids

Country Status (17)

Country Link
US (1) US6410298B1 (pt)
EP (1) EP1032695B1 (pt)
JP (1) JP4376454B2 (pt)
KR (2) KR100796060B1 (pt)
CN (1) CN1201013C (pt)
AT (1) ATE393234T1 (pt)
AU (1) AU759531B2 (pt)
BR (1) BR9814210A (pt)
CA (1) CA2309315C (pt)
CZ (1) CZ299797B6 (pt)
DE (1) DE69839403T2 (pt)
FR (1) FR2774699B1 (pt)
HU (1) HU226018B1 (pt)
IL (2) IL135983A0 (pt)
NO (1) NO329784B1 (pt)
PL (1) PL196606B1 (pt)
WO (1) WO1999025861A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799472B1 (fr) * 1999-10-07 2004-07-16 Aventis Pharma Sa Preparation d'adenovirus recombinants et de banques adenovirales
US6821775B1 (en) * 2000-02-11 2004-11-23 Genvec, Inc. Viral vector encoding pigment epithelium-derived factor
US7653769B2 (en) * 2006-12-14 2010-01-26 International Business Machines Corporation Management of devices connected to infiniband ports
US6591543B2 (en) * 2000-04-14 2003-07-15 Kenneth P. Sabine Top water lure with highly active propeller
KR20010064682A (ko) * 2000-07-01 2001-07-11 김재호 Ｅ1ｂ가 감쇠된 아데노바이러스를 이용한 ｃｄ／5－ｆｃ및 ｈｓｖ－1 ｔｋ／ｇｃｖ의 이중 자멸 유전자 시스템
DE10045687B4 (de) * 2000-09-15 2006-07-06 MICROMUN Privates Institut für Mikrobiologische Forschung GmbH Biotechnikum Greifswald Expressionskassetten und Adenovirusvektoren
US20030087438A1 (en) * 2001-11-02 2003-05-08 Genvec, Inc. E1-revertant-free adenoviral composition
US20030158112A1 (en) * 2002-02-15 2003-08-21 Johns Hopkins University School Of Medicine Selective induction of apoptosis to treat ocular disease
EP1567198A4 (en) * 2002-12-02 2006-05-31 Genvec Inc MATERIALS AND METHOD FOR THE TREATMENT OF EYE DISEASES
JP2007528903A (ja) * 2004-03-12 2007-10-18 ジェンベク、インコーポレイティッド 眼における血管漏出を処置するための物質
US20060188481A1 (en) * 2005-02-22 2006-08-24 Saitama Medical School Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder
EP2118292B1 (en) * 2007-01-30 2011-08-03 Transgene SA Papillomavirus e2 polypeptide used for vaccination
AU2008250520B2 (en) * 2007-05-15 2013-10-31 Transgene S.A. Vectors for multiple gene expression
DK3093345T3 (da) 2007-07-26 2019-06-24 Uniqure Ip Bv Baculovirusvektorer omfattende gentagne kodende sekvenser med differentielle foretrukne kodoner
WO2010057650A1 (en) * 2008-11-21 2010-05-27 Bavarian Nordic A/S Vector comprising multiple homologous nucleotide sequences
WO2010085660A2 (en) 2009-01-23 2010-07-29 Roger Williams Hospital Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same
WO2012021730A2 (en) * 2010-08-11 2012-02-16 Genvec, Inc. Respiratory syncytial virus (rsv) vaccine
EP2784155B1 (en) 2011-11-24 2018-06-13 Viromed Co. Ltd. Adenovirus producing novel cell line and the use thereof
US9014637B1 (en) * 2013-09-27 2015-04-21 Intel Corporation Dynamic switching frequency control of an on-chip or integrated voltage regulator
CN108203706B (zh) * 2017-11-30 2021-03-26 陕西师范大学 一种用于提高高容量腺病毒包装效率的辅助腺病毒
CN112877358B (zh) * 2021-02-07 2023-02-03 上海市第一人民医院 一种基于5型腺病毒序列的重组质粒及应用
CN119432919B (zh) * 2024-11-12 2025-07-01 北京因美未来生物医药科技有限公司 减少复制型腺病毒污染的病毒载体及构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726285B1 (fr) * 1994-10-28 1996-11-29 Centre Nat Rech Scient Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
CA2226833C (en) * 1995-03-24 2009-12-15 Genzyme Corporation Adenovirus vectors for gene therapy
WO1997000326A1 (en) * 1995-06-15 1997-01-03 Introgene B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy

Also Published As

Publication number Publication date
WO1999025861A2 (fr) 1999-05-27
JP4376454B2 (ja) 2009-12-02
NO329784B1 (no) 2010-12-20
AU3129400A (en) 2000-12-14
HUP0101827A3 (en) 2003-08-28
PL340601A1 (en) 2001-02-12
BR9814210A (pt) 2000-10-03
CA2309315C (fr) 2011-06-14
ATE393234T1 (de) 2008-05-15
HUP0101827A2 (hu) 2001-09-28
CZ299797B6 (cs) 2008-11-26
KR100796060B1 (ko) 2008-01-21
US6410298B1 (en) 2002-06-25
CA2309315A1 (fr) 1999-05-27
CN1201013C (zh) 2005-05-11
DE69839403D1 (de) 2008-06-05
WO1999025861A3 (fr) 1999-07-01
JP2003504004A (ja) 2003-02-04
NO20002504D0 (no) 2000-05-15
EP1032695B1 (fr) 2008-04-23
NO20002504L (no) 2000-05-15
HU226018B1 (en) 2008-03-28
FR2774699A1 (fr) 1999-08-13
IL135983A (en) 2008-11-26
PL196606B1 (pl) 2008-01-31
KR20010032146A (ko) 2001-04-16
DE69839403T2 (de) 2009-05-28
CZ20001791A3 (cs) 2000-08-16
AU759531B2 (en) 2003-04-17
KR20070103483A (ko) 2007-10-23
CN1278302A (zh) 2000-12-27
FR2774699B1 (fr) 2003-10-03
EP1032695A2 (fr) 2000-09-06

Similar Documents

Publication Publication Date Title
IL135983A0 (en) Adenovirus vectors and method for reducing homologous recombination phenomena
HU9603155D0 (en) Papillomavirus vaccines
HUP9800730A3 (en) System for the expression of heterologous antigens as fusion proteins
MX9802764A (es) Promotor homologo fuerte procedente de un hamster.
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
EP0886644A4 (en) LONGWAVE FLUORESCENT PROTEINS
IL130198A0 (en) Methods for purifying viruses
IL117459A0 (en) DNA encoding papillomavirus type 18
IT1266734B1 (it) Gruppo per la molatura di lastre di vetro.
HUP0001837A3 (en) Novel dnas and process for producing proteins by using the same
ZA9710114B (en) Method for the expression of genes.
IL122412A0 (en) Recombinant viral nucleic acids
GB9622965D0 (en) Sv40-derived dna constructs comprising exogenous dna sequences
EP1020524A4 (en) BIOLUMINESCENT MUTANT PROTEIN AND PROCESS FOR PRODUCING THE SAME
WO1998018950A3 (de) Aav-dna mit helfervirus-sequenzen
GB9422688D0 (en) Process for generating DNA markers
AU5397398A (en) Process for the expression of genes of the dengue viruses
ZA982255B (en) Process for the preparation of arylmalonates.
ZA956775B (en) Process for the manufacture of pentafluoroethane
AU3037797A (en) Generation of replicative molecules in vivo
DE69531678D1 (de) Rekombinatie viren,ihre herstellung und ihre verwendung in der gentherapie
GB9422687D0 (en) Process for generating DNA markers
AU1801699A (en) Creation of heteroimmunity amongst ctx$g(f): methods and compounds for the construction of improved (v. cholerae) vaccines
HUP0002281A3 (en) Method for the production of vaccines against cell surface proteins
AU1846495A (en) Process for the purification of 1,3-dihalobenzene from an isomeric mixture of dihalobenzenes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed